Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms Degronimer 1 |
Target |
Action degraders |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H52ClN9O3S |
InChIKeyKAFZWFVFEFZAKD-HTIIIDOHSA-N |
CAS Registry2259851-83-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | United States | 15 Feb 2019 |